1. Home
  2. ENTG vs HOLX Comparison

ENTG vs HOLX Comparison

Compare ENTG & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entegris Inc.

ENTG

Entegris Inc.

HOLD

Current Price

$148.88

Market Cap

17.7B

Sector

Industrials

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$76.02

Market Cap

16.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTG
HOLX
Founded
1966
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Medical Electronics
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7B
16.9B
IPO Year
2000
1995

Fundamental Metrics

Financial Performance
Metric
ENTG
HOLX
Price
$148.88
$76.02
Analyst Decision
Buy
Hold
Analyst Count
10
13
Target Price
$133.67
$77.89
AVG Volume (30 Days)
2.3M
25.5M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
0.28%
N/A
EPS Growth
N/A
N/A
EPS
1.55
0.79
Revenue
$3,196,600,000.00
$4,100,500,000.00
Revenue This Year
$9.27
$4.74
Revenue Next Year
$9.50
$5.03
P/E Ratio
$93.75
$96.23
Revenue Growth
N/A
1.74
52 Week Low
$66.32
$51.90
52 Week High
$159.15
$76.07

Technical Indicators

Market Signals
Indicator
ENTG
HOLX
Relative Strength Index (RSI) 62.62 69.09
Support Level $107.76 $75.10
Resistance Level N/A N/A
Average True Range (ATR) 5.59 0.19
MACD 0.83 0.03
Stochastic Oscillator 62.21 95.19

Price Performance

Historical Comparison
ENTG
HOLX

About ENTG Entegris Inc.

Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: